Multinational Biopharmaceutical Company Licenses LabVantage’s Sapphire™ To Support Its Core Biomaterial Research for Cancer and Immunological Therapies
Bridgewater, NJ. September 5, 2007. LabVantage today announced that a global biopharmaceutical company has licensed LabVantage’s Sapphire Laboratory Information Management Suite (LIMS) to automate their research process and establish an enterprise-wide knowledgebase of research data. The global biopharmaceutical company concentrates on the discovery, development and commercialization of groundbreaking therapies designed to treat cancer and immunological diseases. They have successfully marketed a number of commercial products as well as cellular and tissue therapeutics.
The division deploying Sapphire is responsible for supplying research expertise to multiple product development teams and pioneered the recovery of stem cells from human placental tissue following the completion of a full-term, successful pregnancy. Prior to deploying Sapphire, they had to manually intercede to facilitate the efficient entry and routing of work requests for approval. They plan to use Sapphire’s automated request approval/rejection routing functionality, along with a number of flexible workflow capabilities, to eliminate the manual intervention and streamline their workflow process, expediting the initiation and execution of their work order requests. Further, they intend to store test results derived from these work requests in Sapphire, providing a central knowledge repository accessible enterprise-wide through a zero footprint web browser.
“We are very excited about this global biopharmaceutical company’s decision to deploy Sapphire and we are thrilled with the rapid pace of the project from kick-off to full functionality solution acceptance in less than six months,” stated Jim Aurelio, CEO & President of LabVantage, “As the complexity of mission-critical research intensifies, Sapphire continues to support research & discovery organizations with innovative research management solutions that enable them to convert their research into commercialized products and therapeutics.”
About LabVantage. LabVantage Solutions, Inc., an innovative global provider of enterprise solutions tailored for leading laboratories, serves discovery, development, formulation, process research, raw material testing, and quality management laboratories across multiple industries. LabVantage Sapphire, a zero-footprint laboratory information management suite, is tailored to manage an organization’s critical laboratory information across its worldwide R&D pipeline and manufacturing supply chain to optimize productivity and more effectively share knowledge. A Chatterjee Management Group company, LabVantage is headquartered in Bridgewater, NJ, U.S.A., with direct or partner coverage in Austria, Belgium, Canada, China, Denmark, Estonia, Finland, France, Germany, Hong Kong, India, Jordan, Latvia, Lithuania, Malaysia, Netherlands, Norway, Oman, Qatar, Saudi Arabia, Singapore, South Africa, Sweden, Switzerland, Taiwan, Thailand, United Arab Emirates, and United Kingdom. Further information about LabVantage and LabVantage Sapphire is available at www.labvantage.com.
LabVantage, Sapphire and their respective logos are trademarks or registered trademarks of LabVantage Solutions, Inc. in the U.S and other countries around the world.
